Galderma Q1 Sales Surge 25.5% on Strong US Demand

Key Performance Highlights

Swiss skincare firm Galderma announced a significant 25.5% increase in first-quarter sales in constant-currency terms, reaching $1.47 billion. The company reported these strong results on Thursday, attributing the growth to robust market performance and consumer demand.

U.S. Market Drives Growth

The primary driver for this growth was the United States market, which saw an impressive 41.5% year-on-year sales leap. This brisk business activity underscores the company's strong position and brand resonance in the region, solidifying its market leadership.

Navigating Economic Headwinds

Galderma expressed confidence in its ability to navigate a volatile economic environment. The company stated that its exposure to U.S. tariffs is expected to remain manageable and has factored the impact into its confirmed full-year guidance for products like Sculptra and Restylane.

Summary and Outlook

Based on the strong start to the year, Galderma's full-year guidance is increasingly de-risked. The company continues to demonstrate resilience and a clear strategy for managing potential trade challenges while capitalizing on market opportunities.

FAQ

Q: What were Galderma's total sales in the first quarter?
A: Galderma's first-quarter sales reached $1.47 billion, a 25.5% increase in constant-currency terms.

Q: Which market was the main driver of Galderma's growth?
A: The U.S. market was the main driver, with a 41.5% year-on-year sales increase.

Source: Investing.com